DK1648531T3 - Anvendelse af aseptiske aktive stoffer i PMMA-knoglecementer - Google Patents

Anvendelse af aseptiske aktive stoffer i PMMA-knoglecementer

Info

Publication number
DK1648531T3
DK1648531T3 DK04762421T DK04762421T DK1648531T3 DK 1648531 T3 DK1648531 T3 DK 1648531T3 DK 04762421 T DK04762421 T DK 04762421T DK 04762421 T DK04762421 T DK 04762421T DK 1648531 T3 DK1648531 T3 DK 1648531T3
Authority
DK
Denmark
Prior art keywords
pmma bone
cements
active substances
bone cements
aseptic active
Prior art date
Application number
DK04762421T
Other languages
Danish (da)
English (en)
Inventor
Frank Schilke
Berthold Nies
Hanns Pietsch
Original Assignee
Biomet Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomet Deutschland Gmbh filed Critical Biomet Deutschland Gmbh
Application granted granted Critical
Publication of DK1648531T3 publication Critical patent/DK1648531T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04762421T 2003-07-18 2004-07-16 Anvendelse af aseptiske aktive stoffer i PMMA-knoglecementer DK1648531T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10332680A DE10332680A1 (de) 2003-07-18 2003-07-18 Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen
PCT/DE2004/001571 WO2005009495A1 (de) 2003-07-18 2004-07-16 Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen

Publications (1)

Publication Number Publication Date
DK1648531T3 true DK1648531T3 (da) 2009-01-12

Family

ID=34071754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04762421T DK1648531T3 (da) 2003-07-18 2004-07-16 Anvendelse af aseptiske aktive stoffer i PMMA-knoglecementer

Country Status (15)

Country Link
US (1) US20060275339A1 (pt)
EP (1) EP1648531B1 (pt)
JP (1) JP2006528008A (pt)
CN (1) CN1826146B (pt)
AT (1) ATE409499T1 (pt)
AU (1) AU2004259159B2 (pt)
CA (1) CA2531488C (pt)
CY (1) CY1108640T1 (pt)
DE (2) DE10332680A1 (pt)
DK (1) DK1648531T3 (pt)
ES (1) ES2313046T3 (pt)
PL (1) PL1648531T3 (pt)
PT (1) PT1648531E (pt)
SI (1) SI1648531T1 (pt)
WO (1) WO2005009495A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006220567A1 (en) * 2005-03-07 2006-09-14 The Regents Of The University Of California Medical implants
DE102005048131A1 (de) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Antimikrobielle Kunststoffzusammensetzung mit niedriger Elutionsrate und langer Wirksamkeit
DE102008021473A1 (de) * 2008-04-29 2009-11-12 Heraeus Kulzer Gmbh Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
WO2009143236A1 (en) * 2008-05-20 2009-11-26 Albert Einstein Healthcare Network Compositions and methods for the treatment of skeletal metastatic lesions and fractures
DE102009004368A1 (de) * 2009-01-08 2010-07-15 Heraeus Kulzer Gmbh Dentalmaterialien enthaltend antimikrobielle Wirkstoffe zur Verhinderung von Plaque-Anlagerungen
DE102009035970A1 (de) * 2009-08-04 2011-02-17 Heraeus Kulzer Gmbh Antimikrobiell ausgestattete Dentalmaterialien, insbesondere zur Verhinderung von Plaqueanlagerungen
EP2384733B1 (de) * 2010-05-07 2016-07-27 Ivoclar Vivadent AG Antimikrobielle Dentalwerkstoffe
US8834772B2 (en) 2011-12-07 2014-09-16 Biomet Manufacturing, Llc Antimicrobial methacrylate cements
DE102012022419A1 (de) * 2012-11-16 2014-05-22 Heraeus Medical Gmbh Antiseptischer Polymethylmethacrylat-Knochenzement
DE102016212091A1 (de) 2016-07-04 2018-01-04 Heraeus Medical Gmbh Antiseptischer Polymethylmethacrylat-Knochenzement
CN114053477B (zh) * 2020-08-03 2023-06-06 首都医科大学附属北京朝阳医院 一种抗骨髓瘤纳米骨水泥及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL200235A (pt) * 1954-09-10
DE3513938A1 (de) * 1985-04-18 1986-10-23 Merck Patent Gmbh, 6100 Darmstadt Cytostatikahaltiges pharmakadepot
DE3542972A1 (de) * 1985-12-05 1987-06-11 Merck Patent Gmbh Pharmakadepot
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
EP0450117A1 (de) * 1990-04-02 1991-10-09 Infectless S.A. Ringerlösung und dessen Anwendung als bakterizid wirkendes lokales Wundbehandlungsmedikament
DE59406509D1 (de) * 1993-05-26 1998-08-27 Fresenius Ag Antiinfektivum
GB9322137D0 (en) * 1993-10-27 1993-12-15 Logical Water Limited A system and method for defining a process structure for performing a task
US6046143A (en) * 1994-08-22 2000-04-04 Becton Dickinson And Company Water soluble lubricant for medical devices
DE19641775A1 (de) * 1996-08-22 1998-02-26 Merck Patent Gmbh Verfahren zur Herstellung von wirkstoffhaltigen Knochenzementen
DE19718648A1 (de) * 1997-05-02 1998-11-05 Merck Patent Gmbh Verfahren und Vorrichtung zur Herstellung von steril verpacktem Knochenzement
US5980573A (en) * 1997-05-12 1999-11-09 Shaffner; Richard L. Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
US6245111B1 (en) * 1997-05-12 2001-06-12 Richard L. Shaffner Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
AUPO907697A0 (en) * 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
US6020396A (en) * 1998-03-13 2000-02-01 The Penn State Research Foundation Bone cement compositions
EP0985413A1 (de) * 1998-08-06 2000-03-15 Jörg Michael Dr. Dr. Schierholz Medizinprodukte mit retardierter pharmakologischer Aktivität und Verfahren zu ihrer Herstellung
CA2343529C (en) * 1998-09-08 2004-11-23 Microban Products Company Antimicrobial acrylic material
US6494717B1 (en) * 1998-09-24 2002-12-17 Advantage Dental Products, Inc. Calcified tissue facing preparation containing an antimicrobial agent
DE19938704C1 (de) * 1999-08-14 2001-10-31 Ivoclar Vivadent Ag Verfahren zur Herstellung von Reaktionssystemen zur Implantation in den menschlichen und tierischen Körper als Knochenersatz, die u.a. Calcium und Phosphor enthalten
JP2004520088A (ja) * 2000-08-15 2004-07-08 サーモディックス，インコーポレイティド 薬剤混和マトリックス
ES2192141B1 (es) * 2002-02-08 2005-02-16 Consejo Sup. Investig. Cientificas Formulaciones acrilicas de curado en frio con activadores derivados de diaminodifenilcarbinol de baja toxicidad.

Also Published As

Publication number Publication date
PL1648531T3 (pl) 2009-03-31
SI1648531T1 (sl) 2009-02-28
AU2004259159B2 (en) 2008-11-20
WO2005009495A1 (de) 2005-02-03
CA2531488C (en) 2010-09-28
JP2006528008A (ja) 2006-12-14
CN1826146A (zh) 2006-08-30
AU2004259159A1 (en) 2005-02-03
ATE409499T1 (de) 2008-10-15
CN1826146B (zh) 2010-12-01
EP1648531A1 (de) 2006-04-26
PT1648531E (pt) 2008-12-05
DE10332680A1 (de) 2005-02-17
US20060275339A1 (en) 2006-12-07
DE502004008161D1 (de) 2008-11-13
CA2531488A1 (en) 2005-02-03
EP1648531B1 (de) 2008-10-01
ES2313046T3 (es) 2009-03-01
CY1108640T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
CY1108640T1 (el) Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα
DK1440148T3 (da) Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår
DE60038695D1 (de) Gegen bakterielle 16s und 23s rrnas gerichtete ungeladene antisense oligonukleotide und deren verwendungen
SE0102315D0 (sv) Compounds
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
HK1108896A1 (en) Prodrugs of 2,4-pyrimidinediamine compounds and their uses
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ATE407998T1 (de) Reinigungsmittel
ATE434451T1 (de) Calciumphosphat materialien mit verbesserter osteoinduktivität
CO5690590A2 (es) Uso de tigeciclina sola o en combinacion con rifampicina para tratar la osteomielitis y/o la artritis septica
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
UY28313A1 (es) Nonadepsipeptidos acilados
AR028041A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
UY28542A1 (es) Amidas macrocíclicas antibacterianas
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
CR10255A (es) "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos"
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
AU2001238332A1 (en) Method of sterilizing articles
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE442122T1 (de) Dentalmaterial mit bakteriostatischen und/oder bakteriziden substanzen
CL2004001343A1 (es) Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana.
CL2004001005A1 (es) Compuestos derivados de macrolidos de 15 miembros, sustituidos en posicion 4", procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topicas.